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1. Introduction 
1.1 Polymerase Chain Reaction (PCR) 
The polymerase chain reaction (PCR) is a rapid scientific method for generating a 106-107-
fold increase in the number of copies of discrete DNA or RNA sequences (Boehm,1989; 
Imboden et al,1993). The use of PCR technology has greatly increased the ability to study on 
genetic material. PCR is a rapid and reliable molecular biology technique that allows quick 
replication of mainly DNA, the starting material can be a single molecule of rRNA or 
mRNA. It was developed by Kary Mullis in 1983, and he was awarded the Nobel Prize in 
1993. PCR method is useful in situations of limited amount of DNA sample as in forensics, 
prenatal testing, because it amplifies a single or a few copies of DNA creating millions of 
copies of the region(1). The ability to quickly produce large quantities of genetic material 
has enabled significant scientific advances including DNA fingerprinting and sequencing of 
the human genome. As PCR technology allows taking specimen of genetic material even 
from just one cell, copy its genetic material several times, this facilitates genetic studies. 
Currently, besides research purposes, PCR technology is heavily used in diagnosis and 
patient management especially for viral diseases such as AIDS and hepatitis. Other than 
detection of infectious organisms, this technology is also useful for determination of genetic 
polymorphisms or mutations of individuals (Stahlberg,2011).  
The method relies on thermal cycles of repeated heating and cooling of the reaction for DNA 
melting. Double stranded DNA can be disrupted by heat or high pH, giving rise to single 
stranded DNA. The single stranded DNA serves as a template for synthesis of a 
complementary strand by replicating enzymes, DNA polymerases. In order to imitate the 
accelerated  form of DNA replication for a gene region, a special form of DNA polymerase is 
used. This DNA polymerase should be resistant to the thermal denaturation. Most of the 
PCR applications employ Taq polymerase, an enzyme isolated from the bacterium Thermus 
aquaticus, but there are some other heat-stable DNA polymerases used by the same 
purpose. Most polymerases require short regions of double stranded nucleic acid to initiate 
synthesis. For in vitro PCR reactions, this can be provided by synthetic oligonucleotides of 
about 21-25 bp that are complementary to the negatice strand of main DNA molecule. Those 
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oligonucleotide sequences are known as ‘primer’ and chosen due to the DNA region that we 
want to amplify. In PCR, two synthetic primers that flank the region of interest are used; one 
primer is complementary to the negative strand of DNA and second primer to the positive 
strand. The primers must be oriented that DNA synthesis proceeds across the regions 
defined by the primers. By this way, only a single region of giant DNA molecule can be 
amplified. As only one amplification is not enough, PCR is a cyclic process to generate 106-
107-fold increase in a gene region; each PCR cycle contains three steps. Those thermal 
cycling steps are necessary separate two strands in the DNA double helix at a high 
temperature by a process called DNA melting. There are three main sequentially repeating 
steps of PCR: 
• Denaturation of DNA duplex (94-98°C),  
• Annealing of primers (37-60°C),  
• Extention (elongation) of primers by polymerase reaction (~72°C) 
In the denaturation step, the purpose is to separate strand to be ready for replication, 
denaturation temperature is higher than the other steps. In the annealing step, at a lower 
temperature, each strand is used as  templates for DNA synthesis. The selectivity of PCR 
results from this step by the usage of primers complementary to the targeted DNA region 
under specific thermal cycling conditions. After this, there is extention step continuing by the 
heat-stable DNA polymerase to amplify the target DNA region (Boehm,1989).  
After 20 cycles of amplification, a million copies of DNA can be generated from a single 
copy. After several rounds of amplification (about 40 times), the PCR product is analysed on 
an agarose gel an sis abundant enough to be detected with an ethidium bromide stain.  
After this stage, to detect the changes on the DNA sequence, the classical PCR-RFLP method 
(the next heading) can be used. But also specific DNA sequences can be detected without 
opening the reaction tube (Higuchi, 1992). Recently, after first preliminary studies the 
technique developed to get both structural and quantitative informations about the 
amplified DNA region by real-time PCR devices using flourescent dyes, as we will mention 
in following headings. 
1.2 PCR-Restriction Fragment Length Polymorphism (PCR-RFLP) method 
In contemporary, there are several forms of PCR that are extensively modified to perform a 
wide array of genetic manipulations. PCR-RFLP (PCR-restriction fragment length 
polymorphism) is one of those that was preliminary to most of classified PCR methods. 
RFLP is a technique referring to a difference between restriction enzyme sites on DNA 
samples, broken into pieces (digested) by those restriction enzymes and the resulting 
fragments are separated according to their lengths by gel electrophoresis.  
Restriction endonucleases are specific enzymes that can cleave specific nucleotide 
sequences; because of that property, it is possible for them to discriminate nucleotide 
changes in DNA. Sometimes they can effect the loci other than the target one, but the 
important part of the procedure is the possible polymorphism or mutation loci to be 
detected whether the cleavage site is intact or not. If there is a change in the cleavage site of 
restriction endonuclease, it will not cleave the site, or by addition of the mutation, there may 
ocur a previously not existing cleavage site. 
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Fig. 1. An example of RFLP results from our laboratories. As shown in the figure, there is a 
50 bp marker to compare with our own results and detect the basepair (bp) length. After 
treatment and incubation with specific restriction enzyme:  
• The uncut homozygote cases (having the same alleles) were expected to be having only 
one 314 bp band (as in number 2).   
• The cut homozygote cases (having the same alleles) were expected to be having three 
bands of 217, 62, 35 bp (as in number 3 and 6) 
• The heterozygote cases (having two separate alleles) were expected to be having four 
bands of 252, 217, 62, 35 bp (as in number 1,4 and 5) 
1.3 Types of PCR 
• Conventional PCR: This is the DNA-based PCR, primers target specific sequences on 
DNA and amplification follows the usual steps of denaturation, annealing and elongation. 
• Reverse transcription-PCR: mRNA or rRNA can be the main material to be amplified. 
The first step is the enzymatic ‘reverse transcriptase’ reaction to transcribe RNA to 
cDNA. Subsequent steps are similar to conventional PCR steps (Tania et al, 2006). 
• Asymmetric PCR: It can be used for generation of single strand for sequencing studies.  
This can be done by adjusting primer concentrations to favor one strand; by this way after 
first cycles, only the strand complementary to the first strand continues to be copied. 
• Nested PCR: In this type of PCR, there are two stages of the procedure; in the first part, 
by using a set of primers, a fragment is amplified. After this, by using another primer 
set, a sub-region of the previously amplified region is re-amplified. Main aim is to 
increase sensitivity and specificity.  
• Real-time PCR. 
2. Real-time PCR  
Real-time PCR (PCR with real time) is also known as kinetic PCR, QPCR, QRT- PCR. 
Automated thermal cycling devices have been improved by using Taq DNA polymerase 
which is thermostable and continued to be developed by fluorescence luminescence 
techniques( Higuchi et al,1992; Logan j et al, 2009.). Real-time PCR is easy to perform, 
providing reliable results with high accuracy as well as rapid quantification. Quantification 
of polymorphic DNA regions and genotyping single nucleotide polymorphisms are 
detected by using the real-time PCR reaction. For gene expression analyses, the mRNA 
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levels can be done quantitatively by reverse transcriptase–PCR (RT-PCR) reaction (Tanie Eet 
al, 2006). By this way, it is possible to monitor gene outputs numerically in many different 
fields, from the drug-resistant tumor cells to the chemotherapy scanning and also to the 
molecular determination of tumor stages. The use of gene expression analysis is getting 
increased in many notable fields of biological research. Gene profiling opens new 
possibilities to classify the disease into subtypes and guide a differentiated treatment. 
This method has been preferred especially in the samples, the analysis of which cannot be 
possible, or in the samples, the cytogenetic analysis of which are turned out as auxiliary 
techniques to the molecular analysis. Therefore, it has became one of the indispensable 
methods. The introduction of real-time PCR technology has significantly improved  and 
simplified the quantification of nucleic acids, and this technology has become a valuable tool 
for many scientist working in different disciplines. Especially in the field of molecular 
diagnosis, real-time PCR-based assays took their advantage (Pfaffl, 2004).  
2.1 Real-time PCR protocols 
Real-time PCR  has been preferred as one of the favored methods in molecular studies and 
in routine analyses, since the process takes short time as 20-30 minutes,it provides fast 
heating and cooling cycles of 30-40 times, in addition to these, it benefits the control of PCR 
reaction on a computer monitor (Wittwer, 1997). High sensitivity of real-time PCR makes 
the technique applicable to very small samples, such as fine needle aspirates. Real-time PCR 
instruments can simultaneously amplify and detect, eliminating the need to open tubes 
containing PCR products and therefore reducing the risk of future contamination (Lyon, 
2009).  Additionally nested PCR and touchdown PCR can be performed using real-time PCR 
Machine. There are various real-time PCR machines that are used mostly in laboratory 
experiments: 
- ABI Prism 7700  
- LightCycler2/Lightcycler 480 Probes (Roche, Mannheim, Germany)  
- i-cycler (BioRad)   
2.2 Probing techniques 
Today, fluorescence is exclusively used as the detection method in real-time PCR. The 
fluorescent reporters can be divided into two categories: nonspecific and sequence-specific 
labels (Wilhelm, 2003).  
Nonspecific labels: These are DNA-binding dyes such as SYBR Green I ( Wittwer et al,1997; 
Zipper et al, 2004.) and BEBO (Bengtsson et al, 2003), which become strongly fluorescent 
when they are bound to double-stranded DNA. SYBR Green I binds all double-stranded 
DNA molecules regardless of their sequence. The Double-stranded DNA bindind dye SYBR 
Green I is proven to be effective. Maximum excitation of SYBR Green I dye occurs at 497 nm. 
Maximal emission of DNA stained with SYBR Green I occurs at 521 nm. The specifity and 
sensitivity of SYBR Green I detection can be monitored by performing a melting curve 
analysis after using the amplification reaction with external standard. 
Differentiation of single point mutant alleles from wild type allele is not possible with SYBR 
Green I but it is possible to detect small deletions/insertions (10 to 20 bp). 
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2.2.1 Hybridization probes (pair of sequence-specific, single-labeled probes) 
Sequence-specific probes are based on oligonucleotides or their analogs that one or two 
fluorescent dyes are coupled.  
There are some types of probes with two dyes (Holland et al 1991; Tyagi et al, 1996; Tyagi et 
al, 1998; Caplin et al 1999): a) hydrolysis probes (TaqMan® probes), b) molecular beacons, c) 
hybridization probes. 
a. Hydrolysis probes: This probe is a single oligonucleotide labeled with two different 
fluorophores. The fluorophore near the 3' end(acceptor)  acts as a fluorescence emission 
”quencher” of the other one near the 5' end(donor) (Holland et al 1991). As soon as Taq 
DNA polymerase hydrolyzes the probe via its 5' exonuclease activity during a 
combined annealing/extension step, the 5' fluorophore (donor) is liberated. Therefore, 
its emission can no longer be suppressed by the quencher and can be measured in the 
fluorimeter. TaqMan real-time PCR is one of the two types of quantitative PCR 
methods, and  uses a fluorogenic probe which is a single stranded oligonucleotide of 20-
26 nucleotides and is designed to bind only the DNA sequence between two PCR 
primers. In this case, two primers with a preferred product size of 50-150 bp, a probe 
with a fluorescent reporter or fluorophore such as 6-carboxyfluorescein (FAM) and 
tetrachlorofluorescin (TET) and quencher such as tetramethylrhodamine (TAMRA) 
covalently attached to its 5' and 3' ends are required, respectively (Giller et al, 2011). 
b. Hybridization probes: In this case, there are two oligonucleotides that hybridize to 
adjacent internal sequences of the same amplicon (Witther et al, 2011). For instance, the 
5' oligonucleotide (donor) has a fluorescence in label at its 3' end. The 3' 
oligonucleotide(acceptor) has either LightCycler-Red 640 or LightCycler-Red 705 at its 
5' end. Only after hybridization to the template DNA, two probes come in close 
proximity, resulting in fluorescence resonance energy transfer (FRET) between the two 
fluorophores. During FRET, fluorescein, the donor fluorophore, is excited especially by 
the light source of the LightCycler Instrument, and part of the excitation energy is 
transferred to either LightCycler-Red 640 or LightCycler-Red 705, the acceptor 
fluorophores. Emitted fluorescence of these acceptor fluorophores are then measured 
by the LightCycler Instrument. Specific detections are performed with these probes. For 
example, the mutation detections  are analysed  via the external and internal standards .   
c. Molecular Beacon Probes: A molecular beacon is one oligonucleotide labeled with two 
different fluorophores, an acceptor and a donor. Due to the specific secondary structure 
formed by the oligonucleotide (beacon), acceptor (quencher) and donor dyes are in 
close proximity. A molecular beacon unfolds while binding to the growing PCR 
product, thereby separating the dyes and enhancing the fluorescence of the donor dye. 
Four different fluorophores can be designed to detect different point mutations 
simultaneously (Vincent et al, 2005 ). 
2.3 Melting curve analysis  
At the beginning of a melting curve analysis, the reaction temperature is low and the 
fluorescence signal is high. As the temperature steadily increases, the fluorescence will 
suddenly drop as the reaction reaches the melting point (Tm) of each DNA fragment. More 
specific analysis of PCR reactions can be performed with SYBR Green I because of its 
specific melting behaviour, identification/differentiation of multiple specific PCR products 
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(multiplex PCR ) with  SYBR Green I, genotyping  and mutation analyses with hybridization 
probes. Melting Curve Analysis has many advantages (Wittwer et al, 2009). Just like gel  
 
Fig. 2. Heterozygote result indicating two  melting curves (53.0 ⁰C and 62.0 ⁰C) 
 
Fig. 3. Wild type result which indicate one melting curve (62.0 ⁰C)                            
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electrophoresis, melting point analysis permits clear identification of the amplicon, since 
each PCR product possesses a characteristic melting point. Moreover, nonspecific products 
(primer dimers) can also be identified by this method. If performed with hybridization 
probes, melting point analysis can also detect point mutations. For instance, the acquired 
Janus Kinase 2(JAK2) V617F point mutation can be found in more than 90% patient with 
polycytaemia, and in 50% of patients with other chronic myeloproliferative diseases. For 
instance in the figures 2-4, our own laboratory results are given. Myeloproliferative 
neoplasms JAK2V617F-mutation analysis results are shown as melting curve analyses. The 
genotype is identified by running  a melting curve with specific melting points (Tm). 
 
Fig. 4. Mutant result which indicate one melting curve (53.0 ⁰C)                            
2.4 High-Resolution Melting Analysis (HRMA) 
High resolution melting is a post-PCR-based method for detecting DNA sequence variation 
by measuring changes in the melting of a DNA duplex (Martin-Nunez et al, 2011). Melting 
analysis using new instruments have been designated for high-resolution melting curve 
analysis (HRM or HRMA) based on its ease of use, simplicity, flexibility, cost-effectivity, 
nondestructive nature, superb sensitivity, and specificity (Vossen et al, 2009). It enables 
researchers to rapidly detect and categorize genetic mutations and single nucleotide 
polymorphisms(SNPs), identify new genetic variants without sequencing (gene scanning) or 
determine the genetic variation in a population (e.g. viral diversity) prior to sequencing. 
SYBR®Green I is introduced into a sensitive conventional dye for PCR product melting 
analysis. High-resolution melting analysis have been used clinically to detect somatic 
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changes in select exons of oncogenes such as EGFR,53 KRAS,54 PDGFRA,55 KIT,56 BRAF,57 
andTP53  ( Bastien et al, 2008). 
2.5 Gene expression analysis 
Conventional microarrays have limitations in flexibility, speed, cost, and sensitivity. Gene 
expression analysis by microarray techniques and real-time PCR offers new possibilities to 
classify malignant tumors, such as lymphomas, into more distinct subtypes for diagnosis 
and treatment (Schmit et al, 2010; Bagg et al, 1999; Stahlberg et al, 2005. ). The study of 
biological regulation usually involves gene expression assays and requires quantification of 
RNA frequently. In the past, conventional gel- or blot-based techniques were used for these 
assays. However, these techniques often have limitations in speed, sensitivity, dynamic 
range, and reproducibility required by current experimental systems. In contrast, real-time 
PCR methods, can easily meet these requirements. Reverse transcription PCR (RT-PCR) is a 
common and powerful tool for highly sensitive RNA expression profiling. Quantification by 
real-time PCR may be performed as either absolute measurements using an external 
standard, or as relative measurements, comparing the expression of a reporter gene with 
that of a presumed constantly expressed reference gene (Stahlberg et al, 2005).  
A  flow- chart, represents the steps of  Real-time PCR and its applications, is given in Figure 5.  
 
Fig. 5. Real-time PCR Flow-chart  
2.6 Epigenetic studies with PCR 
Epigenetic information is usually lost during the PCR because of the insensitivity of DNA 
polymerase, it cannot distinguish between methylated and unmethylated cytosines. After 
PCR, any methylated allele will be extremely diluted. Therefore, something must be done to 
preserve methylated form of DNA. Treatment with sodium bisulfite will deaminate cytosine 
to uracil, the rate of deamination of 5-methylcytosine to thymine is slower than the 
conversion of cytosine to uracil, thus it is assumed that the only cytosines remaining after 
sodium bisulfite treatment are derived from 5-methylcytosines. By this way, during 
subsequent PCR cycles, uracil residues are replicated as thymine residues, and 5-
methylcytosine residues are replicated as cytosines. The efficiency of the method is about 
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99% in appropriate conditions, but this method needs intense attention while chosing 
primers and arranging study conditions(Gulley et al.).   
3. PCR-based studies in cancer research 
The advances in molecular techniques provide new molecular targets for diagnosis and 
therapy of cancer. These advances can provide both researchers and clinicians with precious 
information concerning the behavior of tumors. Therefore,  these tumors can detect at earlier 
stages when the tumor burden is smaller and be potentially more curable currently. After 
the human genome project has completed, the application of highthroughput technologies 
for polymorphism detection for explaining molecular mechanism for complex disease has 
created very important opportunities (Khoury,1997).  
Single nucleotide polymorphisms (SNPs) offers widespread use in gene mapping of genetic 
disorders, in the delineation of genetic influences in multifactorial diseases such as cancer, 
cardiovascular disease, in haplotype mapping, and as genetic markers to predict responses 
to drugs (Riddick et al, 2005). However, for example, there are some inconsistent results 
regarding the relationship between the presence of polymorphic forms of genes encoded 
detoxifying enzymes and chemotherapeutic response. It has been reported that the genetic 
polymorphism analysis in peripheral blood may not be enough representative for the status 
in tumour tissue. For instance, Uchida et al reported that individuals heterozygous for the 
28-bp polymorphism in thymidylate synthase (TS) gene may have increased risk for cancer 
that are homozygous for this polymorphism due to loss of one allele during 
carcinogenesis(Uchida et al, 2004). They also showed that the response to 5-FU-based 
chemotherapy in these cases was comparable to cases where the individual was 
homozygous. Therefore, it may be excellent to determine the genotype of polymorphisms in 
tumour cells than in peripheral blood. 
Some data obtained from combined genotype studies have demonstrated that these data 
may have significance for models of cancer prognosis or treatment. But, many researchers 
suggest that larger studies will be needed also to investigate the effect of specific treatment 
modalities in cancer. While investigating the post-initiation stages of cancer, four basic parts 
can be dedicated to gene polymorphisms affecting: (a)growth control of cell (cell 
proliferation, differentiation and death); (b)factors involved in tumour invasion and 
metastasis (immune and inflammatory responses, extracellular matrix remodelling, 
angiogenesis and cell adhesion); (c)effects of hormones and vitamins on growing tumours; 
(d)outcome of cancer therapy (cancer pharmacogenetics) (Loktionov, 2004). Quantitation of 
gene expression in tumor or host cells has another an enormous importance for 
investigating the gene patterns responsible for cancer development, progression and 
response or resistance to therapy.  
Analysis of transcriptional activity of tumor cells or detection of possible new tumor 
markers by polymerase chain reaction (PCR), reverse transcriptase PCR (RT-PCR) and  
quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) techniques have the 
potential to change cancer diagnosis and treatment (Mocellin, 2003). New molecular 
tecniques for diagnosis offers the promise of accurately matching patient with treatment. It 
has been shown that there is a resultant significant effect on improved disease outcome. 
Currently, the real-time reverse transcription polymerase chain reaction (qRT-PCR), has a 
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potential to become an important analytical tecnique for the mRNA detection  in tissue 
biopsies or body fluids. qRT-PCR is especially promising in prognostic assays and 
monitoring response to treatment for cancer patients. It is known that histopathological 
staging in cancer defines patient prognosis. However, there are some limitations in the 
prognostic heterogeneity of patients within a given tumour stage.  According to this view, 
not all patients with lymph node-negative are treated and not all patients with lymph node-
positive tumours die from their cancer. So, more accurate staging protocols are needed for 
detection clinical tumour staging by using molecular techniques.  
Gene expression analysis is one of the most important parameter that utilises the qRT-PCR 
assay's potential for generating quantitative data (Skrzypski, 2008; Schuster et al, 2004). It is 
reported that the detection of disseminated tumor cells in peripheral blood obtained from 
colorectal cancer patients by RT-PCR could be an effective method for identifying patients 
for adjuvant therapy. It is known that the mRNA for prostate specific antigen (PSA) is 
expressed only by prostatic cells. RT-PCR are suggested as a potentially more sensitive 
assay for the detection of cells expressing PSA mRNA in peripheral blood or in 
extraprostatic tissues. Some studies suggest that the molecular detection of circulating 
tumor cells (CTC) and micrometastases may help develop new prognostic markers in 
patients with solid tumors (Ghossein et al, 2000). It has been reported that prostatic tissue 
specific markers and melanoma related transcripts were detected by RT PCR in the 
peripheral blood, bone marrow and lymph nodes of patients with localized and advanced 
tumors. Currently, many reliable methods emerged with fast and efficient mechanisms for 
screening and monitorizing large populations for genetically linked traits and for cancer-
related genes discovery.  
In addition to gene expression profiling, real-time PCR is also useful to detect chromosomal 
aberrations. Non-random chromosomal translocations are frequently associated with a 
variety of cancers, particularly hematologic malignancies and childhood sarkomas (Peter et 
al, 2006). For example t(15,17) translocation is found only in the leukemic cells. Only in 
patients with acute promyelocytic leukemia (APL) and the other forms of leukemia, t(1;19) 
translocation is found with  B-cell precursor acute lympoblastic leukemia (ALL). 
Quantitative analysis provide small number of remaining malignant cells (minimal residual 
disease, MRD) in patients to be revealed whose disease is in a clinical remission. Therefore, 
quantitative results are very important in terms of detection in malignancies and MRD. For 
example, BCR-ABL quantification monitors MRD and therapy of chronic myelogenous 
leukemia (Lyon et al, 2009). Using the real-time PCR Instrument as a closed tube, rapid 
amplification and real-time fluorescence detection system, for example quantitative 
measurement of the  BCR-ABL expression level can be performed with a minimum risk of 
cross contamination. Relative expression levels of different samples may be calculated by 
standardizing the amount of BCR-ABL transcripts in a sample to the amount of an 
endogenous expressed housekeeping gene. The values for BCR-ABL and housekeeping gene 
for each sample are calculated by the real-time PCR software by the comparing the crossing 
points to the standard curve. A normalized target value (the ratio of BCR-
ABL/housekeeping ) is then derived by dividing the amount of BCR-ABL by the amount of 
housekeeping gene. The chromosomal aberration examples in various leukemia types can 
be detected by RNA quantification, shown  in Table 1. On the other hand,  melting analysis 
of  the PCR product or the probe is used to confirm detection of the correct product. 
www.intechopen.com
 
PCR-RFLP and Real-Time PCR Techniques in Molecular Cancer Investigations 
 
565 
ACUTE LYMPHOBLASTIC LEUKEMIA
(ALL) 
ACUTE NON-LYMPHOBLASTIC 
LEUKEMIA (ANLL) 
t(9;22) BCR-ABL Translocation  t(15;17) PML-RAR┙  Translocation  
t(1;19) E2A-PRL Translocation  t(8,21) AML1-ETO Translocation  
t(12;21) TEL-AML1 Translocation  inv (16) CBF┚- MYH11  Inversion  
t(4;11) MLL-AF4  Translocation  CRONIC MYELOID LEUKEMIA (KML) 
Multidrug resistance  1 (MDR1)  t(9;22)     BCR-ABL  Translocation  
Table 1. The chromosomal aberrations that can be detected by RNA quantification.  
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